Funding for this research was provided by:
Ludwig Institute for Cancer Research
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA08748)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01 AI034206)
Howard Hughes Medical Institute
Parker Institute for Cancer Immunotherapy
Cancer Research Institute
W. H. is supported by an Irvington-Cancer Research Institute Postdoctoral Fellowship.
Z.-M.W. is supported by a Bruce Charles Forbes Fellowship.
Received: 22 January 2021
Accepted: 14 July 2021
First Online: 23 August 2021
: A.Y.R. is a co-founder and Science Advisory Board member of and holds stock options in Vedanta Bioscience and Sonoma Biotherapeutics. The other authors declare no competing interests.